Molbio Diagnostics Limited
Molbio Diagnostics Limited scores highest on Nitro (94) and lowest on Price (7). Its PosiPenta is 50.36 out of 100, around the middle of similar companies.
On the Penta Grid this week, Molbio Diagnostics Limited is Grid #83 of 168 in the Healthcare sector in India, and Grid #1,113 of 2,356 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Molbio Diagnostics Limited | 50.36 | 7 | 69 | 94 | 44 | 38 |
| Vijaya Diagnostic Centre Limited | 49.93 | 12 | 56 | 76 | 52 | 55 |
| NATCO Pharma Limited | 55.05 | 94 | 43 | 11 | 58 | 70 |
| Poly Medicure Limited | 53.20 | 40 | 66 | 38 | 48 | 74 |
| Syngene International Limited | 44.73 | 44 | 55 | 13 | 40 | 71 |
| Indegene Limited | 62.61 | 53 | 63 | 96 | 63 | 39 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 108.88 |
| P/B ratio | 15.52 |
EEarnings
| Trailing EPS | ₹14.46 |
| Forward EPS | ₹35.85 |
NNitro
| Price | 1574.40 |
| 52-week high | 1686.80 |
| 52-week low | 926.35 |
| Fall from 52-week high | 6.7% |
TTorque
| Return on equity (ROE) (calculated) | 14.25% |
| Debt-to-equity | 0.34 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹18,143 Cr |
| Promoter holding | 41.29% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Molbio Diagnostics Limited's PosiPenta score?
Molbio Diagnostics Limited's PosiPenta is 50.36 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Molbio Diagnostics Limited stand on the Penta Grid?
On the Penta Grid this week, Molbio Diagnostics Limited is Grid #83 of 168 in the Healthcare sector in India, and Grid #1,113 of 2,356 in India.
Which PosiPenta pillar is strongest for Molbio Diagnostics Limited?
Nitro (momentum), with a score of 94 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Molbio Diagnostics Limited?
Price (valuation), with a score of 7 out of 100: much weaker than most similar companies.
Has Molbio Diagnostics Limited's PosiPenta changed since last week?
Yes, it rose 5.57 points, from 44.79 to 50.36.
PositoAI is for research and education only and is not investment advice.